These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1508400)

  • 21. Free amino acids in post-mortem cerebral cortices from patients with Alzheimer-type dementia.
    Arai H; Kobayashi K; Ichimiya Y; Kosaka K; Iizuka R
    Neurosci Res; 1985 Aug; 2(6):486-90. PubMed ID: 4047524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memantine in the treatment of dementia.
    Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
    Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevalence of depressive disorders in dementia].
    Vilalta-Franch J; López-Pousa S; Llinàs-Reglà J
    Rev Neurol; 1998 Jan; 26(149):57-60. PubMed ID: 9533206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamate and other CSF amino acids in Alzheimer's disease.
    Pomara N; Singh R; Deptula D; Chou JC; Schwartz MB; LeWitt PA
    Am J Psychiatry; 1992 Feb; 149(2):251-4. PubMed ID: 1734749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients.
    D'Aniello A; Fisher G; Migliaccio N; Cammisa G; D'Aniello E; Spinelli P
    Neurosci Lett; 2005 Nov; 388(1):49-53. PubMed ID: 16039064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia.
    Nemes Z; Fésüs L; Egerházi A; Keszthelyi A; Degrell IM
    Neurobiol Aging; 2001; 22(3):403-6. PubMed ID: 11378245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preliminary study of free amino acids in the postmortem temporal cortex from Alzheimer-type dementia patients.
    Arai H; Kobayashi K; Ichimiya Y; Kosaka K; Iizuka R
    Neurobiol Aging; 1984; 5(4):319-21. PubMed ID: 6152305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The significance of cerebral white matter lesions in vascular dementia--from psychiatric aspects].
    Matsushita M; Kawasaki H; Wada Y; Otomo E
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1351-3. PubMed ID: 2099881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia.
    Wallin A; Blennow K; Rosengren LE
    Dementia; 1996; 7(5):267-72. PubMed ID: 8872418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia.
    Tohgi H; Abe T; Hashiguchi K; Saheki M; Takahashi S
    Neurosci Lett; 1994 Aug; 177(1-2):139-42. PubMed ID: 7824166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia.
    Parnetti L; Reboldi GP; Gallai V
    Neurology; 2000 Feb; 54(3):735-7. PubMed ID: 10680813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.
    Smesny S; Stein S; Willhardt I; Lasch J; Sauer H
    J Neural Transm (Vienna); 2008 Aug; 115(8):1173-9. PubMed ID: 18584113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients.
    Wada-Isoe K; Wakutani Y; Urakami K; Nakashima K
    Acta Neurol Scand; 2004 Aug; 110(2):124-7. PubMed ID: 15242421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino acid levels and ratios in serum and cerebrospinal fluid of patients with optic neuropathy in Cuba.
    Gonzalez-Quevedo A; Obregon F; Fernandez R; Santiesteban R; Serrano C; Lima L
    Nutr Neurosci; 2001; 4(1):51-62. PubMed ID: 11842876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of low-dose gabapentin for aggressive behavior in vascular and Mixed Vascular/Alzheimer Dementia.
    Cooney C; Murphy S; Tessema H; Freyne A
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):120-5. PubMed ID: 23686029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
    Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
    Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the validity of deriving clinical dementia rating (CDR) global scores from independently-obtained functional rating scale (FRS) scores in vascular dementia with and without Alzheimer's disease.
    Lanctôt KL; Hsiung GY; Feldman HH; Masoud ST; Sham L; Herrmann N
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1174-6. PubMed ID: 19768698
    [No Abstract]   [Full Text] [Related]  

  • 38. [A modified vascular dementia scale].
    Krzymińska E; Rossa G; Krzymiński S
    Psychiatr Pol; 1991; 25(6):28. PubMed ID: 1841395
    [No Abstract]   [Full Text] [Related]  

  • 39. Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects.
    Fisher G; Lorenzo N; Abe H; Fujita E; Frey WH; Emory C; Di Fiore MM; D' Aniello A
    Amino Acids; 1998; 15(3):263-9. PubMed ID: 9871505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia.
    Tarkowski E; Ringqvist A; Blennow K; Wallin A; Wennmalm A
    Dement Geriatr Cogn Disord; 2000; 11(6):322-6. PubMed ID: 11044777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.